Kibler et al., 1978 - Google Patents
Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculationKibler et al., 1978
- Document ID
- 6554171782280771277
- Author
- Kibler R
- Solvay M
- ter Meulen V
- Publication year
- Publication venue
- Pathobiology
External Links
Snippet
H-2 antigen compatibility of effector spleen cells and target cells was necessary for cell- mediated cytotoxicity (CMC) after both 1 and 2 intraperitoneal inoculations of 6/94 virus into mice. T cells were responsible for both primary and secondary CMC reactions. Neither …
- 231100000023 Cell-mediated cytotoxicity 0 title abstract description 12
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Woodroofe et al. | Serological relationships within the poxvirus group: an antigen common to all members of the group | |
| Cox et al. | Rabies virus glycoprotein. II. Biological and serological characterization | |
| Campbell et al. | Fowl plague virus from man | |
| US4517304A (en) | Production of viral antigens | |
| Bøe et al. | Guillain-Barré syndrome after vaccination with human diploid cell rabies vaccine | |
| Pavia et al. | Failure to detect cell-mediated cytotoxicity against Chlamydia trachomatis-infected cells | |
| Bennink et al. | Influenzal pneumonia: early appearance of cross-reactive T cells in lungs of mice primed with heterologous type A viruses. | |
| Russell et al. | Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion | |
| Pokrić et al. | Application of the immune complex for immune protection against viral disease | |
| Kreth et al. | Cell-Mediated Cytotoxicity Against Measles Virus in SSPE: II. Analysis of Cytotoxic Effector Cells | |
| Kibler et al. | Antibody-mediated cytotoxicity after measles virus infection | |
| Sugamura et al. | Role of Sendai virus fusion-glycoprotein in target cell susceptibility to cytotoxic T cells | |
| WO1996041874A1 (en) | Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection | |
| Sugamura et al. | Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells | |
| Slenczka et al. | A critical study of monkey sera for the presence of antibody against the Marburg virus | |
| Kibler et al. | Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculation | |
| Berinstein et al. | Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract of the Mycobacterium sp. wall | |
| Härfast et al. | Interactions between human lymphocytes and paramyxovirus-infected cells: Adsorption and cytotoxicity | |
| Liebhaber et al. | STUDIES OF A MYXOVIRUS RECOVERED FROM PATIENTS WITH INFECTIOUS HEPATITIS: I. ISOLATION AND CHARACTERIZATION | |
| Potter et al. | Antibody response of hamsters to A2/Hong Kong virus vaccine after priming by heterotypic virus infection | |
| Pettersen | Resistance to avirulent Toxoplasma gondii in normal and vaccinated rats | |
| Härfast et al. | Enhanced Cytotoxicity of Human Lymphocytes Against Rabies‐Infected Cells by Rabies‐Specific Antibodies | |
| Aaslestad | Antigenic Composition oi Rabies Virus | |
| George et al. | Route‐Related Variation in the Immunogenicity of Killed Salmonella enteritidis Vaccine: Role of Antigen Presenting Cells | |
| FUJITA | RESEARCH ON DENGUE IN TISSUE CULTURE: IV. Serologic Responses of Human Beings to Combined Inoculations of Attenuated, Tissue-Cultured Type I Dengue Virus and Yellow Fever Vaccine |